AKT1 and laryngeal carcinoma: While in the present study, wortmannin and LY294002 are the specific inhibitors of PI3K, so we can better understand the role of PI3K/Akt pathway in the radiosensitivity of laryngeal carcinoma and its relationship with GLUT-1[28].